Winship Cancer Instituted of Emory University
Welcome,         Profile    Billing    Logout  
 10 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dorff, Tanya
PLANE-PC, NCT04848337: Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Recruiting
2
50
US
Pembrolizumab, Keytruda, Lenvatinib, Lenvima
University of Michigan Rogel Cancer Center, Merck Sharp & Dohme LLC, Hoosier Cancer Research Network
Prostate Cancer Metastatic, Neuroendocrine Tumors
12/24
12/24
Nazha, Bassel
PLANE-PC, NCT04848337: Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Recruiting
2
50
US
Pembrolizumab, Keytruda, Lenvatinib, Lenvima
University of Michigan Rogel Cancer Center, Merck Sharp & Dohme LLC, Hoosier Cancer Research Network
Prostate Cancer Metastatic, Neuroendocrine Tumors
12/24
12/24
NCT05756569: Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Recruiting
2
25
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, tomography, Enfortumab Vedotin, AGS 22ME, AGS-22M6E, Anti-Nectin 4 ADC ASG-22CE, Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E, ASG-22CE, Enfortumab Vedotin-ejfv, Padcev, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Questionnaire Administration
Emory University, National Cancer Institute (NCI), Seagen Inc., Astellas Pharma Inc, Merck Sharp & Dohme LLC
Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Neoplasm, Malignant Ureter Neoplasm, Malignant Urethral Neoplasm, Metastatic Bladder Carcinoma, Stage III Bladder Cancer AJCC v8, Stage IV Bladder Cancer AJCC v8, Unresectable Bladder Carcinoma, Urachal Adenocarcinoma, Bladder Adenocarcinoma
12/26
12/27
NCT05733351: Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Suspended
1
30
US
Abiraterone, CB 7598, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, tomography, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Enzalutamide, ASP9785, MDV3100, Xtandi, FDG-Positron Emission Tomography, FDG, FDG-PET, FDG-PET Imaging, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, PSMA PET Scan, Prostate-specific Membrane Antigen PET, PSMA PET, Vudalimab, Anti-PD-1/Anti-CTLA-4 XmAb20717, Anti-PD1/CTLA4 Bispecific Antibody XmAb20717, PD-1 x CTLA-4 Bispecific Antibody XmAb20717, PD-1 x CTLA-4 Dual Checkpoint Inhibitor XmAb20717, XmAb 20717, XmAb20717
Emory University, National Cancer Institute (NCI), Xencor, Inc.
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
12/26
12/27
Edet, Victor
PLANE-PC, NCT04848337: Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Recruiting
2
50
US
Pembrolizumab, Keytruda, Lenvatinib, Lenvima
University of Michigan Rogel Cancer Center, Merck Sharp & Dohme LLC, Hoosier Cancer Research Network
Prostate Cancer Metastatic, Neuroendocrine Tumors
12/24
12/24

Download Options